Clinical Trial(s): Namenda® (memantine) - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial(s): Namenda® (memantine)

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: To improve cognitive function
Number of Subjects: 146
Medication: Namenda®
Location: CA|OR|TX|WA
Contact Information
Jose Aparicio
(323) 224-5333

Funding:

Forest Laboratories, Inc.

Description

A double-blinded, placebo-controlled study of Namenda for cognitive problems in MS

Share